Theravance (Nasdaq:THRX) is a biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Recent Mentions on Fool.com
- High-Yield Horror: These 3 Stocks Yielding 12% (or Higher) Could Face Huge Dividend Cuts
- There Appears to Be No Easy Path to Success for GlaxoSmithKline and Theravance
- Why Theravance Inc. Shares Crashed 21% Today
- 3 Reasons a Dividend Stock Could Worry Investors
- Why Shares of Theravance Inc Sank 12% in July